Association between dipeptidyl peptidase-4 inhibitors and increased risk for bullous pemphigoid within 3 months from first use: A 5-year population-based cohort study using the Japanese National Database.
Hirohito KuwataYuichi NishiokaTatsuya NodaShinichiro KuboTomoya MyojinTsuneyuki HigashinoYutaka TakahashiHitoshi IshiiTomoaki ImamuraPublished in: Journal of diabetes investigation (2021)
Although DPP-4is were associated with increased risk for BP, the risk was particularly significant within 3 months from first use.
Keyphrases